The price will be temporarily extended again as Astellas Korea, which had been expected to plunge last year due to the government's adjustment to insurance prices, has prolonged its refusal to lower the price of Betmiga PR.

The 14th administration of the Seoul Administrative Court has decided to extend the suspension until the 30th day of the ruling on Betmiga PR-related litigation among the "pharmaceutical reimbursed list and upper limit price table" announced by the MOHW on June 23 last year. Suspension means suspending the government's price reduction measures until the lawsuit is closed.

Last year, the MOHW included the drug in the list of items that cut the government's authority adj